Mortality in cancer patients with COVID-19 who are admitted to an ICU or who have severe COVID-19: a systematic review and meta-analysis
AR Nadkarni, SC Vijayakumaran, S Gupta… - JCO Global …, 2021 - ascopubs.org
PURPOSE There are scarce data to aid in prognostication of the outcome of critically ill
cancer patients with COVID-19. In this systematic review and meta-analysis, we investigated …
cancer patients with COVID-19. In this systematic review and meta-analysis, we investigated …
[HTML][HTML] PICU mortality of children with cancer admitted to pediatric intensive care unit a systematic review and meta-analysis
RM Wösten-van Asperen, JPJ van Gestel… - Critical Reviews in …, 2019 - Elsevier
Background Outcomes for children diagnosed with cancer have improved dramatically over
the past 20 years. However, although 40% of pediatric cancer patients require at least one …
the past 20 years. However, although 40% of pediatric cancer patients require at least one …
Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational …
É Azoulay, P Castro, A Maamar, V Metaxa… - The Lancet …, 2021 - thelancet.com
Background Chimeric antigen receptor (CAR) T-cell therapy can induce side-effects such as
cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome …
cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome …
Critical illness in patients with hematologic malignancy: a population-based cohort study
Purpose To describe the modern incidence and predictors of ICU admission for adult
patients newly diagnosed with a hematologic malignancy. Methods We conducted a …
patients newly diagnosed with a hematologic malignancy. Methods We conducted a …
[HTML][HTML] Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database
A Cortegiani, F Madotto, C Gregoretti, G Bellani… - Critical Care, 2018 - Springer
Background The aim of this study was to describe data on epidemiology, ventilatory
management, and outcome of acute respiratory distress syndrome (ARDS) in …
management, and outcome of acute respiratory distress syndrome (ARDS) in …
Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study
FG Zampieri, TG Romano, JIF Salluh… - Intensive Care …, 2021 - Springer
Purpose To describe trends in outcomes of cancer patients with unplanned admissions to
intensive-care units (ICU) according to cancer type, organ support use, and performance …
intensive-care units (ICU) according to cancer type, organ support use, and performance …
[HTML][HTML] High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation
C Saillard, J Lambert, M Tramier, L Chow-Chine… - PLoS …, 2022 - journals.plos.org
Background High-flow nasal cannula (HFNC) is increasingly used in critically ill cancer
patients with acute respiratory failure (ARF) to avoid mechanical ventilation (MV). The …
patients with acute respiratory failure (ARF) to avoid mechanical ventilation (MV). The …
High flow nasal therapy in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis
Purpose The role of high-flow nasal therapy (HFNT) as compared to conventional oxygen
therapy (COT) in immunocompromised patients admitted to intensive care unit (ICU) with …
therapy (COT) in immunocompromised patients admitted to intensive care unit (ICU) with …
Critical care management of chimeric antigen receptor T cell–related toxicity. Be aware and prepared
E Azoulay, A Shimabukuro-Vornhagen… - American journal of …, 2019 - atsjournals.org
CAR (chimeric antigen receptor) T cells (CARTs) are genetically engineered T cells that
express CARs, with impressive clinical activity in relapsed and refractory hematologic …
express CARs, with impressive clinical activity in relapsed and refractory hematologic …
Vasopressin versus norepinephrine for the management of septic shock in cancer patients: the VANCS II randomized clinical trial
LA Hajjar, C Zambolim, A Belletti… - Critical care …, 2019 - journals.lww.com
Objectives: Previous trials suggest that vasopressin may improve outcomes in patients with
vasodilatory shock. The aim of this study was to evaluate whether vasopressin could be …
vasodilatory shock. The aim of this study was to evaluate whether vasopressin could be …